Zobrazeno 1 - 10
of 677
pro vyhledávání: '"Literatur Kommentiert"'
Autor:
Schneider G
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 1996 Jun; Vol. 172 (6), pp. 342-3.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anca-Ligia Grosu, Simon K. B. Spohn
Publikováno v:
Strahlentherapie Und Onkologie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84fad95a0ef764d99b011db7787cd4ea
https://doi.org/10.1007/s00066-021-01882-2
https://doi.org/10.1007/s00066-021-01882-2
Autor:
Johanna Richter, Jürgen Dunst
Publikováno v:
Strahlentherapie Und Onkologie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe1c137357bc9dafa762466d5aec26b1
https://doi.org/10.1007/s00066-021-01788-z
https://doi.org/10.1007/s00066-021-01788-z
Publikováno v:
Strahlentherapie Und Onkologie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8a969998ef1b04ad62245940cb6eaf
https://doi.org/10.1007/s00066-021-01880-4
https://doi.org/10.1007/s00066-021-01880-4
Publikováno v:
Strahlentherapie Und Onkologie
Cardiac radiotherapy (RT) may be effective in treating heart failure (HF) patients with refractory ventricular tachycardia (VT). The previously proposed mechanism of radiation-induced fibrosis does not explain the rapidity and magnitude with which VT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ba1c47be458753a0c17df2a218a0a04
http://europepmc.org/articles/PMC8789705
http://europepmc.org/articles/PMC8789705
Autor:
Simone Marnitz
Publikováno v:
Strahlentherapie Und Onkologie
Pre-operative immunohistochemical (IHC) biomarkers are not incorporated in endometrial cancer (EC) risk classification. We aim to investigate the added prognostic relevance of IHC biomarkers to the ESMO-ESGO-ESTRO risk classification and lymph node (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0f711be4c7730585096818df22ba0e8
https://doi.org/10.1007/s00066-021-01862-6
https://doi.org/10.1007/s00066-021-01862-6
Autor:
Peters, Christina, Dalle, Jean-Hugues, Locatelli, Franco, Poetschger, Ulrike, Sedlacek, Petr, Buechner, Jochen, Shaw, Peter J, Staciuk, Raquel, Ifversen, Marianne, Pichler, Herbert, Vettenranta, Kim, Svec, Peter, Aleinikova, Olga, Stein, Jerry, Güngör, Tayfun, Toporski, Jacek, Truong, Tony H, Diaz-de-Heredia, Cristina, Bierings, Marc, Ariffin, Hany, Essa, Mohammed, Burkhardt, Birgit, Schultz, Kirk, Meisel, Roland, Lankester, Arjan, Ansari Djaberi, Marc Georges, Schrappe, Martin, von Stackelberg, Arend, Balduzzi, Adriana, Corbacioglu, Selim, Bader, Peter, IBFM Study Group, IntReALL Study Group, I-BFM SCT Study Group, EBMT Paediatric Diseases Working Party
Publikováno v:
Journal of clinical oncology, Vol. 39, No 4 (2021) pp. 295-307
Journal of Clinical Oncology
Journal of Clinical Oncology, 39(4), 295-308. LIPPINCOTT WILLIAMS & WILKINS
Strahlentherapie Und Onkologie
Journal of Clinical Oncology
Journal of Clinical Oncology, 39(4), 295-308. LIPPINCOTT WILLIAMS & WILKINS
Strahlentherapie Und Onkologie
PURPOSE Total body irradiation (TBI) before allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with acute lymphoblastic leukemia (ALL) is efficacious, but long-term side effects are concerning. We investigated whether pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c31dae55370a44311a402016446c585
https://doi.org/10.1200/jco.20.02529
https://doi.org/10.1200/jco.20.02529
Autor:
Josée M. Zijlstra, Stefan Balabanov, Carsten Kobe, Hans Theodor Eich, Richard Greil, Julia Meissner, Alden A. Moccia, Teresa V Halbsguth, Volker Diehl, Paul J Bröckelmann, Judith Dierlamm, Ulrich Keller, Bastian von Tresckow, Christian Baues, Michael Fuchs, Annette Plütschow, Helmut Ostermann, Simone Marnitz, Martin Wilhelm, Sonja Martin, Beate Klimm, Julia Thiemer, Peter Borchmann, Thomas Pabst, Johannes Mohm, Michael Hallek, Andreas Rosenwald, Markus Dietlein, Andreas Hüttmann, Martin Vogelhuber, Max S. Topp, Martin Sökler, Andreas Engert, Andrea Kerkhoff, Miriam Ahlborn, Georg Kuhnert
Publikováno v:
The Lancet Oncology, 22(2), 223-234. Lancet Publishing Group
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045(20)30601-X
Strahlentherapie Und Onkologie
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045(20)30601-X
Strahlentherapie Und Onkologie
Background: Combined-modality treatment consisting of chemotherapy and consolidation radiotherapy is standard of care for patients with early-stage unfavourable Hodgkin lymphoma. However, the use of radiotherapy can have long-term sequelae, which is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f13d466acfe65ac8d5c77ff231c4382
https://doi.org/10.1016/s1470-2045(20)30601-x
https://doi.org/10.1016/s1470-2045(20)30601-x